Navigation Links
Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C
Date:11/5/2007

atment, changes in mental health as measured by the Hospital Anxiety and Depression Scale (HADS) had recovered to baseline in 67% of the patients taking Albuferon 900 mcg, compared with 57% of the peginterferon alfa-2a patients.

The treatment group taking Albuferon 1200 mcg every two weeks also recorded fewer lost days of work and less impairment of health-related quality of life on treatment than was reported for the peginterferon alfa-2a group.

About Albuferon

Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology. Albuferon results from the genetic fusion of human albumin and interferon alpha. Human albumin is the most prevalent naturally occurring blood protein in the human circulatory system, persisting in circulation in the body for more than 20 days. Research shows that genetic fusion of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of the proteins. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B and a number of cancers.

Albuferon is being developed by HGS and Novartis for the treatment of chronic hepatitis C under a worldwide co-development and commercialization agreement entered into in June 2006. HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, commercial milestone and other payments to HGS could total as much as $507.5 million, including $132.5 million received to date.

About Hepatitis C

Hepatitis C is an inflammation of the liver caused by the hepatitis C virus (HCV). An estimated 170 million people worldwide are infected with the virus, including nearly 4 million people in the United States. When detectable levels of HCV
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ) ... agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL ... secured debt financing. CareView is an information technology provider ... Under the credit agreement, PDL will provide ... in two tranches of $20 million, based upon the ...
(Date:6/29/2015)... , June 29, 2015  Allergan plc ... intends to release second quarter 2015 financial results ... open of the U.S. financial markets. The Company will ... a.m. Eastern Daylight Time on Thursday, August 6, ... to access the call is U.S./ Canada ...
(Date:6/29/2015)... TARRYTOWN, N.Y. , June 29, 2015 /PRNewswire/ ... today announced that the Proceedings of the ... a paper demonstrating that the Company,s proprietary VelociGene ... the rapid identification and preclinical validation of potential ... and treatment of Middle East Respiratory Syndrome (MERS). ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5
... DURHAM, N.C., May 1, 2012 Heart IT, ... approved zero footprint medical imaging workstation, WebPAX®, announced ... "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow ... any computing platform with a standard Internet web ...
... 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a ... the treatment of Parkinson,s disease and other nervous ... selected to present in the Emerging Companies Showcase ... Meeting on May 2nd, 2012 in New York ...
Cached Medicine Technology:U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 2Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 3
(Date:6/30/2015)... ... June 30, 2015 , ... The campaign aims to make ... the different forms of digestive disorders over 70 million Americans face and inspiring readers ... system in tip-top shape. , The print component of “Digestive Wellness” is distributed within ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
(Date:6/30/2015)... ... June 30, 2015 , ... It has become fairly common to purchase fresh ... discard the stalks before cooking. Throwing out radish greens, beet leaves and chard stalks ... delicious. It just takes a little knowledge and practice to use them. Josie's ...
(Date:6/30/2015)... ... , ... New Xarelto lawsuit claims proposed for consolidation in ... according to attorneys handling Xarelto lawsuits included in the MDL.* The ... for plaintiffs’ attorneys in filing new claims, according to court documents. Drafts of ...
(Date:6/30/2015)... ... June 30, 2015 , ... When it comes to volunteering abroad, not ... associated costs will be too high. However, there are affordable programs to be had ... experience at minimal cost. One such volunteer named Uzma Aishah, a student at the ...
Breaking Medicine News(10 mins):Health News:Mediaplanet’s “Digestive Wellness” Campaign Urges You To Listen to What Your Stomach Is Telling You and Talk About It 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 2Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 3Health News:Whole Vegetable Cooking for Home Cooks: Josie's Organics Encourages Using All Parts of Vegetables – from Root to Stalk – Every Day 4Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3
... ... Torque Calculator App for the Apple iPhone and iTouch. The innovative torque application is the ... San Diego, ... Calculator App for the Apple iPhone and iTouch. The innovative torque application is the ...
... ... a patent on its crystal deodorant spray, MineralProtect™. MineralProtect™ combines purified alpine fresh ... mechanism that provides the user with liquid crystal deodorant and proven 24 hour odor ... (PRWEB) ...
... ... that detects and reports redundant and error-prone code in COBOL source. Large software systems ... redundancy in COBOL software. Semantic Designs is a Destination z™ Solution provider and the ... , ...
... AAP policy also pushes for warning labels on packaging of ... leading group of pediatricians in the United States is pushing ... and candies, along with new warning labels placed on food ... , "We know what shape, sizes and consistencies pose the ...
... ... ... ... AAPA honors U.S. Surgeon General Regina Benjamin for commitment to patient care , ...
... ... advantages and disadvantages of certain decisions and what they have planned for the future. ... (PRWEB) February ... of certain decisions and what they have planned for the future., , ,WHO: ...
Cached Medicine News:Health News:Flexible Assembly Systems Announces New Torque Calculator App for the iPhone 2Health News:Verdan Receives Patent on Crystal Deodorant Spray 2Health News:Verdan Receives Patent on Crystal Deodorant Spray 3Health News:IBM Enterprise CloneDR Helps Enterprises Transform Bloated COBOL into Clean, Tight, and Maintainable Code 2Health News:IBM Enterprise CloneDR Helps Enterprises Transform Bloated COBOL into Clean, Tight, and Maintainable Code 3Health News:Pediatricians Want Redesign of Hot Dogs, Candy to Curb Kids' Choking 2Health News:Pediatricians Want Redesign of Hot Dogs, Candy to Curb Kids' Choking 3Health News:Pediatricians Want Redesign of Hot Dogs, Candy to Curb Kids' Choking 4Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 2Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 3Health News:UCLA Health System Presents: How to Successfully Implement a Clinical Portal 2Health News:UCLA Health System Presents: How to Successfully Implement a Clinical Portal 3
... headboxes are the latest ... of portable battery-powered EEG ... robust new mechanical design, ... XLTEK's standard MOBEE24plus and ...
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
Medicine Products: